2-piperidone has been researched along with Adenocarcinoma in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergqvist, M; Bergström, S; Ekman, S; Gullbo, J; Lennartsson, J; Sooman, L | 1 |
| Awasthi, V; Sahoo, K; Yadav, VR | 1 |
| Anderson, KI; Lo Re, D; Murphy, PV; Nobis, M; Zhou, Y | 1 |
| Huggett, MT; Keane, MG; Loddo, M; Pereira, SP; Proctor, I; Stoeber, K; Tudzarova, S; Williams, GH | 1 |
| Anant, S; Awasthi, V; Lagisetty, P; Sahoo, K; Vilekar, P | 1 |
| Horowitz, IR; Huang, RP; Liotta, DC; Mancini, A; Sidell, N; Tan, X; Taylor, RN; Wieser, F | 1 |
| Anant, S; Awasthi, V; Dozmorov, MG; Sahoo, K | 1 |
| Akagi, Y; Araki, Y; Hara, H; Kumabe, T; Matono, K; Ogata, Y; Saitsu, H; Sata, M; Shirouzu, K; Tsuda, H | 1 |
| Burzynski, SR | 1 |
| Anant, S; Dieckgraefe, BK; George, R; Hideg, K; Houchen, CW; Kuppusamy, P; Lee, KB; May, R; Ramanujam, RP; Subramaniam, D; Sureban, SM | 1 |
1 review(s) available for 2-piperidone and Adenocarcinoma
| Article | Year |
|---|---|
The present state of antineoplaston research (1).
Topics: Adenocarcinoma; Benzeneacetamides; Brain Neoplasms; Child; Clinical Trials as Topic; Colonic Neoplasms; Complementary Therapies; Gene Expression Profiling; Gene Expression Regulation; Genes, p53; Glioma; Humans; Piperidones; Survival Analysis | 2004 |
9 other study(ies) available for 2-piperidone and Adenocarcinoma
| Article | Year |
|---|---|
Synergistic effects of combining proteasome inhibitors with chemotherapeutic drugs in lung cancer cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Bortezomib; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Line, Tumor; Cisplatin; Deoxycytidine; Drug Therapy, Combination; Gefitinib; Gemcitabine; Humans; Piperidones; Proteasome Inhibitors; Quinazolines; Small Cell Lung Carcinoma; Vinblastine; Vinorelbine | 2017 |
Preclinical evaluation of 4-[3,5-bis(2-chlorobenzylidene)-4-oxo-piperidine-1-yl]-4-oxo-2-butenoic acid, in a mouse model of lung cancer xenograft.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Benzylidene Compounds; Cell Line, Tumor; Dose-Response Relationship, Drug; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Inflammation Mediators; Ki-67 Antigen; Lung Neoplasms; Male; Mice; Mice, Nude; Multimodal Imaging; Phosphorylation; Piperidones; Positron-Emission Tomography; Signal Transduction; Time Factors; Tomography, X-Ray Computed; Transcription Factor RelA; Transfection; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |
Synthesis of migrastatin and its macroketone analogue and in vivo FRAP analysis of the macroketone on E-cadherin dynamics.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cadherins; Cell Adhesion; Cell Movement; Fluorescence Recovery After Photobleaching; Humans; Macrolides; Mice, Nude; Pancreatic Neoplasms; Piperidones; Tumor Cells, Cultured | 2014 |
Cdc7 is a potent anti-cancer target in pancreatic cancer due to abrogation of the DNA origin activation checkpoint.
Topics: Adenocarcinoma; Cell Cycle Proteins; Cell Line, Tumor; Cohort Studies; DNA Replication; G1 Phase Cell Cycle Checkpoints; Humans; Molecular Targeted Therapy; Pancreatic Neoplasms; Piperidones; Protein Serine-Threonine Kinases; Pyrroles; Transfection | 2016 |
CLEFMA-an anti-proliferative curcuminoid from structure-activity relationship studies on 3,5-bis(benzylidene)-4-piperidones.
Topics: Adenocarcinoma; Antineoplastic Agents; Autophagy; Benzylidene Compounds; Cell Line, Tumor; Cell Proliferation; Humans; Lung Neoplasms; Piperidones; Structure-Activity Relationship | 2010 |
Multiple anticancer activities of EF24, a novel curcumin analog, on human ovarian carcinoma cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Benzylidene Compounds; Cell Line, Tumor; Cell Proliferation; Female; Humans; Ovarian Neoplasms; Piperidones; Reverse Transcriptase Polymerase Chain Reaction; RNA; Vascular Endothelial Growth Factor A | 2010 |
The curcuminoid CLEFMA selectively induces cell death in H441 lung adenocarcinoma cells via oxidative stress.
Topics: Active Transport, Cell Nucleus; Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents, Phytogenic; Antioxidants; Benzylidene Compounds; Blotting, Western; Cell Death; Cell Line, Tumor; Cell Proliferation; Curcumin; Dose-Response Relationship, Drug; Flow Cytometry; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glutathione; Humans; Lung Neoplasms; NF-E2-Related Factor 2; Oligonucleotide Array Sequence Analysis; Oxidation-Reduction; Oxidative Stress; Phosphorylation; Piperidones; Reactive Oxygen Species; Time Factors | 2012 |
Long-term survival following treatment with antineoplastons for colon cancer with unresectable multiple liver metastases: report of a case.
Topics: Adenocarcinoma; Aged; Benzeneacetamides; Colectomy; Colonic Neoplasms; Combined Modality Therapy; Electrocoagulation; Humans; Liver Neoplasms; Male; Microwaves; Piperidones; Prognosis; Survivors | 2003 |
Diphenyl difluoroketone: a curcumin derivative with potent in vivo anticancer activity.
Topics: Adenocarcinoma; Animals; Apoptosis; Benzylidene Compounds; Cell Cycle; Cell Growth Processes; Cell Line, Tumor; Colonic Neoplasms; Cyclooxygenase 2; HCT116 Cells; HT29 Cells; Humans; Interleukin-8; Male; MAP Kinase Signaling System; Mice; Mice, Nude; Neovascularization, Pathologic; Piperidones; Stomach Neoplasms; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2008 |